| 股票 | 标签 | 富途行业 | PE | PB | 股息率 | 分红率 | 毛利率 | ROE | 固定资产 | 负债率 | OCF/市值 | 营收增速 | 利润增速 | 近60日 | YTD | 近一年 | 距52周高 | 市值亿 ▾ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 麦克森 MCK | 成长兑现 | 医疗分销 | 24.2 | -24.97 | 0.4% | 9% | 4% | 0% | 4% | 101% | 6.5% | +12% | +46% | +15% | +11% | +31% | 91% | 1059 |
| Cencora COR | 中性 | 医疗分销 | 24.6 | 20.70 | 0.7% | 17% | 4% | 144% | 4% | 98% | 7.6% | +9% | +3% | +18% | -1% | +12% | 88% | 632 |
| 卡地纳健康 CAH | 中性 | 医疗分销 | 34.2 | -19.94 | 0.8% | 28% | 4% | 0% | 7% | 105% | 9.0% | +14% | +9% | +14% | +21% | +66% | 96% | 575 |
| 汉瑞祥 HSIC | 中性 | 医疗分销 | 26.2 | 3.17 | 0.0% | 0% | 31% | 12% | 7% | 57% | 7.0% | +4% | +5% | +14% | +19% | +33% | 97% | 100 |
| Akso Health AHG | 亏损或困境 | 医疗分销 | -28.3 | 4.02 | 0.0% | — | -0% | -10% | 0% | 5% | -1.8% | -6% | +86% | -39% | -48% | -52% | 34% | 7 |
| EDAP TMS FOCL | 亏损或困境 | 医疗分销 | -4.0 | -48.26 | 0.0% | — | 42% | -94% | 14% | 75% | -8.4% | +2% | -42% | -11% | +26% | +52% | 65% | 2 |
| Accendra Health ACH | 亏损或困境 | 医疗分销 | 1.0 | 0.09 | 0.0% | 0% | 47% | -1756% | 8% | 119% | -193.9% | +3% | -204% | -56% | -57% | -78% | 21% | 1 |
| 1药网 YI | 亏损或困境 | 医疗分销 | -0.5 | -0.28 | 0.0% | — | 6% | 0% | 4% | 90% | -38.7% | -9% | -13% | -20% | +35% | -40% | 31% | 0 |
| Cosmos Health COSM | 亏损或困境 | 医疗分销 | -0.4 | 1.33 | 0.0% | — | 12% | -89% | 12% | 72% | -35.8% | +20% | -18% | +20% | -45% | -55% | 21% | 0 |
| 生研生物 HKPD | 中性 | 医疗分销 | -1.8 | 0.64 | 0.0% | — | 10% | -16% | 3% | 25% | -12.1% | -34% | -4099% | -72% | -84% | -90% | 7% | 0 |
| DataMEDS AI MEDS | 亏损或困境 | 医疗分销 | -0.0 | -0.14 | 0.0% | — | -28% | 0% | 3% | 141% | -489.7% | +29% | -1377% | -76% | -95% | -99% | 1% | 0 |
| Synergy CHC SNYR | 亏损或困境 | 医疗分销 | -0.1 | -0.06 | 0.0% | — | 67% | 0% | — | 328% | -249.3% | -13% | -681% | -45% | -94% | -96% | 4% | 0 |
点表头排序。市值单位亿美元;财务为最近年报(futu 筛选器);分红率 = 股息率 × PE;OCF/市值 = 经营现金流 ÷ 市值(无 FCF);距52周高 = 现价 / 52 周最高。